Liquidia Technologies, Inc. (LQDA)
Liquidia Technologies, Inc. (LQDA)
$4.05 USD
Updated Sep 13 12:00am
Add LQDA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
LQDA Stock Chart More Charts
LQDA Price/Volume Stats
| Current price | $4.05 |
| Prev. close | $4.13 |
| Day low | $3.92 |
| Day high | $4.35 |
| 50-day MA | $6.23 |
| 200-day MA | $12.09 |
| 52-week high | $38.46 |
| 52-week low | $3.25 |
| Volume | 49,500 |
| Avg. volume | 90,401 |
| Dividend yield | N/A |
| Market Cap | 75.50M |
Liquidia Technologies, Inc. (LQDA) Company Bio
Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase Ib clinical trials for the treatment of local post-operative pain. The company was founded in 2004 and is based in Morrisville, North Carolina.
Top Stories View All
101 Fresh Upgrades to Start the Week
2900 or 3100: Which Comes Next?
Best & Worst Performing Stock Industries for September 13, 2019
Best & Worst Performing Small Cap Stocks for September 13, 2019
Best & Worst Performing Large Cap Stocks for September 13, 2019
View All Top Stories
Loading social stream, please wait...